🇺🇸 FDA

Intelligence · Clinical Pipeline

Chinese Academy of Pipeline

All ClinicalTrials.gov programs at Chinese Academy of — phase, modality, and trial IDs.

Programs
1,328

Quick answer

Chinese Academy of has 1,328 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Toripalimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Tracheal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  2. Toripalimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Neoadjuvant Therapy

    phase 2 small molecule active

    1 trial

  3. Toripalimab + Chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thymic Epithelial Tumor

    phase 2 small molecule active

    1 trial

  4. Transarterial chemoembolization

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unresectable Colorectal Cancer

    phase 2 other active

    1 trial

  5. UB-421

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HIV-1-infection

    phase 2 mab active

    1 trial

  6. UB-421(25 mg/kg) Q2W

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HIV-1-infection

    phase 2 mab active

    1 trial

  7. UB-621

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Recurrent Genital Herpes

    phase 2 mab active

    1 trial

  8. UC-MSC transplantation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cirrhosis

    phase 2 other active

    1 trial

  9. UC-MSCs

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cirrhosis Due to Hepatitis B

    phase 2 mab active

    1 trial

  10. Umbilical Cord Mesenchymal Stem Cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Spinal Cord Injury

    phase 2 small molecule active

    1 trial

  11. Umbilical Cord Mesenchymal Stem Cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Spinal Cord Injuries

    phase 2 small molecule active

    2 trials

  12. Ursodeoxycholic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 small molecule completed

    1 trial

  13. Utidelone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    phase 2 small molecule active

    1 trial

  14. Vancomycin and bowel lavage

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Slow Transit Constipation

    phase 2 small molecule active

    1 trial

  15. Vebreltinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Potentially Resectable MET-altered Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  16. Venetoclax

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    FLT3 Gene Mutation

    phase 2 small molecule active

    1 trial

  17. Venetoclax, Azacitidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Myeloid Leukemia

    phase 2 small molecule terminated

    1 trial

  18. Vibecotecotamab combined with Putilimab for EGFR-positive refractory biliary malignant tumors

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cancer of Biliary Duct

    phase 2 small molecule active

    1 trial

  19. Vincristine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Precursor Cell Lymphoblastic Leukemia-Lymphoma

    phase 2 small molecule active

    1 trial

  20. Wei Li Bai capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Alzheimer Disease

    phase 2 small molecule terminated

    1 trial

  21. Yi Qi Yang Yin Decoction

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Sjögren Syndrome

    phase 2 small molecule active

    1 trial

  22. Yigansan

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Tourette Disorder

    phase 2 small molecule completed

    1 trial

  23. Zanubrutinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Refractory/Relapsed Autoimmune Hemolytic Anemia

    phase 2 small molecule active

    1 trial

  24. Zanubrutinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Thrombocytopenia

    phase 2 small molecule active

    1 trial

  25. Zanubrutinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mantle Cell Lymphoma

    phase 2 small molecule active

    1 trial

  26. Zanubrutinib, Fludarabine, cyclophosphamide and rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Lymphocytic Leukemia

    phase 2 small molecule active

    1 trial

  27. Zaunbrutinib, Bendamustine and Rituximab for induction therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Waldenström Macroglobulinemia (WM)

    phase 2 small molecule active

    1 trial

  28. Zuberitamab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HSCT

    phase 2 small molecule active

    1 trial

  29. anlotinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sarcoma, Soft Tissue

    phase 2 small molecule active

    1 trial

  30. anti-BCMA CAR-T

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Plasma Cell Leukemia

    phase 2 mab active

    1 trial

  31. anti-BCMA-CAR-T

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    phase 2 mab active

    2 trials

  32. anti-BCMA/CD3 bispecific antibody

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    phase 2 small molecule active

    1 trial

  33. befotertinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NSCLC (Non-small Cell Lung Cancer)

    phase 2 small molecule active

    1 trial

  34. benmelstobart

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    SCLC, Extensive Stage

    phase 2 small molecule active

    1 trial

  35. bortezomib/dexamethasone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acquired Pure Red Cell Aplasia

    phase 2 small molecule completed

    1 trial

  36. cadonilimab combined +paclitaxel (albumin-bound)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Adenocarcinoma

    phase 2 small molecule active

    1 trial

  37. cell sheet pellets and cell sheet fragment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Periodontitis

    phase 2 mab active

    1 trial

  38. cetuximab (Erbitux)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Cancer

    phase 2 small molecule completed

    1 trial

  39. chemotherapy: TS-1, Leucovorin and Gemcitabine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatic Adenocarcinoma

    phase 2 small molecule completed

    1 trial

  40. cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  41. citalopram

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Major Depressive Disorder

    phase 2 small molecule completed

    1 trial

  42. convention therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stroke

    phase 2 small molecule completed

    1 trial

  43. conventional therapy plus low dose hUC-MSCs treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cirrhosis

    phase 2 mab completed

    1 trial

  44. corticosteroids

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Severe Colitis (ASC)

    phase 2 small molecule active

    1 trial

  45. corticosteroids combined with immunoglobulin and romiplostim

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Immune Thrombocytopenia

    phase 2 small molecule active

    1 trial

  46. dapagliflozin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Kidney Injury

    phase 2 small molecule active

    1 trial

  47. deferoxamine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intracerebral Hemorrhage

    phase 2 small molecule active

    1 trial

  48. docetaxel, cisplatin, fluorouracil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Locally Advanced Head and Neck Carcinoma

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Chinese Academy of have?

1,328 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.